Trial
NCT03536208
Biological Effect of Warfarin on Pancreatic Cancer
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Warfarin
Why stopped
no accrual for over 12 months
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-25